Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Interest Coverage: 215.08 (As of Mar. 2026) — 100% Above Median


SHSE:605033 Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
81 GF Score
Price ¥17.37
GF Value ¥22.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shaanxi Meibang Pharmaceutical Group Co Interest Coverage?

Shaanxi Meibang Pharmaceutical Group Co SHSE:605033 +1.82% 81 Interest Coverage is 215.08 as of Mar. 2026, which is 100% above its 10-year median of 107.33. GuruFocus rates SHSE:605033 with a GF Score™ of 81/100 and a GF Value™ of ¥22.13 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 200 Agriculture companies, Shaanxi Meibang Pharmaceutical Group Co ranks better than 90% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Shaanxi Meibang Pharmaceutical Group Co's Operating Income for the three months ended in Mar. 2026 was ¥53.1 Mil. Shaanxi Meibang Pharmaceutical Group Co's Interest Expense for the three months ended in Mar. 2026 was ¥-0.2 Mil. Shaanxi Meibang Pharmaceutical Group Co's interest coverage for the quarter that ended in Mar. 2026 was 215.08. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Shaanxi Meibang Pharmaceutical Group Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage or its related term are showing as below:

SHSE:605033' s Interest Coverage Range Over the Past 10 Years
Min: 18.54   Med: 107.33   Max: 4127.11
Current: 122.71


SHSE:605033's Interest Coverage is ranked better than
90% of 200 companies
in the Agriculture industry
Industry Median: 7.065 vs SHSE:605033: 122.71

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Shaanxi Meibang Pharmaceutical Group Co  (SHSE:605033) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Shaanxi Meibang Pharmaceutical Group Co Interest Coverage Related Terms


Shaanxi Meibang Pharmaceutical Group Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Shaanxi Meibang Pharmaceutical Group Co Interest Coverage Chart

Shaanxi Meibang Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only 42.04 153.75 159.83 4,127.11 163.59

Shaanxi Meibang Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 538.91 282.93 0.00 85.19 215.08

SHSE:605033 vs CTVA, CF, MOS: Interest Coverage Comparison

For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Meibang Pharmaceutical Group Co Interest Coverage vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage falls into.


SHSE:605033
81GF Score
Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shaanxi Meibang Pharmaceutical Group Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Shaanxi Meibang Pharmaceutical Group Co's Interest Expense was ¥-0.4 Mil. Its Operating Income was ¥64.8 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥135.5 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*64.783/-0.396
=163.59

Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Shaanxi Meibang Pharmaceutical Group Co's Interest Expense was ¥-0.2 Mil. Its Operating Income was ¥53.1 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥147.0 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*53.124/-0.247
=215.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 215.08 mean?
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a Interest Coverage of 215.08 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. This is 100% above median its historical median of 107.33. Over the past decade, Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage has ranged from 18.54 to 4,127.11. According to the industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #20 out of 200 companies in the Agriculture industry, placing it in the top 10%.
Is Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage too high?
Shaanxi Meibang Pharmaceutical Group Co's current Interest Coverage of 215.08 is 100% above median its 10-year median of 107.33. Over the past 10 years, this metric has ranged from a low of 18.54 to a high of 4,127.11. The Agriculture industry median Interest Coverage is 7.07. Shaanxi Meibang Pharmaceutical Group Co's value of 215.08 is 2944.3% above this industry median. Based on the distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #20 out of 200 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's Interest Coverage compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #20 out of 200 companies for Interest Coverage. This places Shaanxi Meibang Pharmaceutical Group Co in the top 10% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.07. Shaanxi Meibang Pharmaceutical Group Co's value of 215.08 is 2944.3% above this benchmark. Historically, Shaanxi Meibang Pharmaceutical Group Co's own Interest Coverage has ranged from 18.54 to 4,127.11 over the past decade. While the company's 10-year median is 107.33 vs. the industry median of 7.07, Shaanxi Meibang Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for an Agriculture company?
The median Interest Coverage among Agriculture companies is 7.07, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current Interest Coverage of 215.08 is 2944.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median Interest Coverage is 7.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current Interest Coverage is 215.08, which is 100% above median its own 10-year median of 107.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current Interest Coverage is 215.08, which is 100% above median its 10-year median of 107.33 and 2944.3% above the Agriculture industry median of 7.07. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current Interest Coverage is 215.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?

Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13. GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:605033:

  • Interest Coverage: 215.08 (100% above median its 10-year median of 107.33)
  • GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
  • GF Score™: 81/100 with 3 warning signs
  • Industry Position: 2944.3% above the Agriculture median (#20 of 200)

No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shaanxi Meibang Pharmaceutical Group Co Business Description

Address High-tech Industrial Development Zone, Pucheng County, Shaanxi Province, Weinan, CHN, 715500
Shaanxi Meibang Pharmaceutical Group Co Ltd is engaged in the research and development, production and sales of pesticide formulations.
81GF Score

Get the complete analysis for SHSE:605033

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.37
Price
¥22.13
GF Value